SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Kik who wrote (25776)12/10/1998 2:07:00 PM
From: Tom Latham  Respond to of 119973
 
Good fresh news on GLGC.... (GENE LOGIC) also upgrade on this on today........ maybe some media on this as the day goes on.. Good pull on the news TIM LUKE......



To: Kik who wrote (25776)12/10/1998 2:08:00 PM
From: Gator  Read Replies (3) | Respond to of 119973
 
"Fundamentals are there" ???

ASTM book value is $0.07 per share, so it's trading at 50 times book. Trailing 12 month loss per share is ($1.57). Sales per share is only $0.03 per share. There are no fundamentals here, as with many biotech stocks. They trade on future hopes of FDA approval and market acceptance.

Gator


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News